Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision
5/17/2013 9:59:58 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), today announced that the NASDAQ Listing Qualifications Panel (the “Panel”) has granted the Company’s request for continued listing on The NASDAQ Capital Market pursuant to an extension through June 3, 2013 to evidence compliance with the minimum $1.00 bid price requirement and through July 31, 2013 to evidence compliance with the minimum $2.5 million stockholders’ equity requirement for continued listing on The NASDAQ Capital Market.
Help employers find you! Check out all the jobs and post your resume.